SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-032211
Filing Date
2017-05-12
Accepted
2017-05-12 19:54:10
Documents
2
Period of Report
2017-05-10

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 7295
2 POA DOCUMENT poa.txt EX-24.3_723537 3108
  Complete submission text file 0001209191-17-032211.txt   11905
Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030
Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Issuer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BELLICUM PHARMACEUTICALS, INC. 2130 W. HOLCOMBE BLVD., STE. 800 HOUSTON TX 77030
Business Address
Smith Alan K. (Reporting) CIK: 0001705246 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36783 | Film No.: 17840659